André Hennigs

2.4k total citations · 1 hit paper
65 papers, 1.5k citations indexed

About

André Hennigs is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, André Hennigs has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cancer Research, 27 papers in Pathology and Forensic Medicine and 25 papers in Oncology. Recurrent topics in André Hennigs's work include Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (27 papers) and Breast Implant and Reconstruction (21 papers). André Hennigs is often cited by papers focused on Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (27 papers) and Breast Implant and Reconstruction (21 papers). André Hennigs collaborates with scholars based in Germany, United States and Netherlands. André Hennigs's co-authors include Michael Golatta, Christof Sohn, Fabian Riedel, Jörg Heil, Joerg Heil, Andreas Schneeweiß, Geraldine Rauch, Hans‐Peter Sinn, Erik‐Oliver Glocker and Sarah Jamal and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

André Hennigs

63 papers receiving 1.5k citations

Hit Papers

A Homozygous CARD9 Mutati... 2009 2026 2014 2020 2009 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
André Hennigs 605 384 344 343 322 65 1.5k
Chantal Babb de Villiers 163 0.3× 426 1.1× 188 0.5× 201 0.6× 229 0.7× 39 1.4k
Jane Meisel 412 0.7× 729 1.9× 96 0.3× 116 0.3× 197 0.6× 85 1.7k
Jean-Pierre Vendrell 443 0.7× 677 1.8× 439 1.3× 105 0.3× 314 1.0× 35 1.6k
Joshua Stern 397 0.7× 279 0.7× 183 0.5× 68 0.2× 392 1.2× 69 2.1k
Hélène Péré 181 0.3× 551 1.4× 473 1.4× 65 0.2× 414 1.3× 84 1.8k
Jeffrey Low 287 0.5× 442 1.2× 175 0.5× 78 0.2× 118 0.4× 51 2.0k
Sigrun Smola 223 0.4× 552 1.4× 548 1.6× 68 0.2× 442 1.4× 82 2.0k
Jussi Tarkkanen 212 0.4× 770 2.0× 368 1.1× 200 0.6× 101 0.3× 98 2.2k
Marc K. Wallack 181 0.3× 829 2.2× 592 1.7× 137 0.4× 90 0.3× 109 2.0k
Marlise R. Luskin 143 0.2× 654 1.7× 273 0.8× 291 0.8× 80 0.2× 142 1.8k

Countries citing papers authored by André Hennigs

Since Specialization
Citations

This map shows the geographic impact of André Hennigs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Hennigs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Hennigs more than expected).

Fields of papers citing papers by André Hennigs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Hennigs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Hennigs. The network helps show where André Hennigs may publish in the future.

Co-authorship network of co-authors of André Hennigs

This figure shows the co-authorship network connecting the top 25 collaborators of André Hennigs. A scholar is included among the top collaborators of André Hennigs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Hennigs. André Hennigs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahm, H.H., Manuel Feißt, Hans‐Peter Sinn, et al.. (2024). Evaluation of Ex Vivo Shear Wave Elastography of Axillary Sentinel Lymph Nodes in Patients with Early Breast Cancer. Cancers. 16(24). 4270–4270.
2.
Riedel, Fabian, Manuel Feißt, Christina Gomez, et al.. (2024). Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosis. Insights into Imaging. 15(1). 196–196. 4 indexed citations
4.
Sinn, Hans‐Peter, Manuel Feißt, Christina Gomez, et al.. (2023). Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?. Breast Cancer Research and Treatment. 201(1). 57–66. 1 indexed citations
5.
Riedel, Fabian, et al.. (2022). How to make students satisfied with digital teaching? Investigative results from teaching evaluations in Gynecology and Obstetrics. Archives of Gynecology and Obstetrics. 306(5). 1587–1596. 2 indexed citations
6.
Au, Alexandra von, Lorenz Uhlmann, Laura L. Michel, et al.. (2022). Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer. Archives of Gynecology and Obstetrics. 307(4). 1105–1113. 11 indexed citations
7.
Riedel, Fabian, Benedikt Schaefgen, Hans‐Peter Sinn, et al.. (2020). Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. European Journal of Radiology. 135. 109468–109468. 29 indexed citations
9.
Heil, Jörg, Aba Harcos, Hans‐Peter Sinn, et al.. (2020). Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?. European Journal of Radiology. 128. 109025–109025. 16 indexed citations
10.
Riedel, Fabian, Jörg Heil, Manuel Feißt, et al.. (2019). Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort. Breast Cancer Research and Treatment. 177(2). 457–467. 6 indexed citations
11.
Feißt, Manuel, Jörg Heil, Alexandra von Au, et al.. (2019). Psychometric validation of the Breast Cancer Treatment Outcome Scale (BCTOS-12): a prospective cohort study. Archives of Gynecology and Obstetrics. 300(6). 1679–1686. 5 indexed citations
12.
Michel, Laura L., Justo Lorenzo Bermejo, Alexandra von Au, et al.. (2019). Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index. PLoS ONE. 14(1). e0211337–e0211337. 4 indexed citations
13.
Hennigs, André, Jörg Heil, Annette Wagner, et al.. (2018). Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12). The Breast. 38. 58–65. 13 indexed citations
14.
Riedel, Fabian, Jörg Heil, Michael Golatta, et al.. (2018). Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade. Archives of Gynecology and Obstetrics. 299(4). 1043–1053. 15 indexed citations
15.
Rath, M, Lorenz Uhlmann, Joerg Heil, et al.. (2017). Oncotype DX® in breast cancer patients: clinical experience, outcome and follow-up—a case–control study. Archives of Gynecology and Obstetrics. 297(2). 443–447. 7 indexed citations
16.
Riedel, Fabian, André Hennigs, Benedikt Schaefgen, et al.. (2017). Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer. Breast Care. 12(6). 385–390. 17 indexed citations
17.
Heil, Joerg, Benedikt Schaefgen, Hans‐Peter Sinn, et al.. (2016). Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?. European Journal of Cancer. 69. 142–150. 47 indexed citations
18.
Hennigs, André, Fabian Riedel, Frederik Marmé, et al.. (2016). Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Research and Treatment. 160(3). 491–499. 40 indexed citations
19.
Schaefgen, Benedikt, Hans‐Peter Sinn, Michael Golatta, et al.. (2015). Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?. Annals of Surgical Oncology. 23(3). 789–795. 77 indexed citations
20.
Hennigs, André, Geraldine Rauch, Michael Golatta, et al.. (2015). Long-term objective esthetic outcome after breast-conserving therapy. Breast Cancer Research and Treatment. 153(2). 345–351. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026